A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50 to 64 Years of Age Without High-Risk Conditions for Severe Coronavirus Disease 2019 (COVID-19)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
Related studies linked through entity extraction aliases.